ArticleiScience2019

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Luke D Jasenosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.